Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland

References

• Witjes JA, Bruins M, Cathomas R, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer 2022. European association of urology guidelines. 2022 Edition. Vol. presented at the EAU Annual Congress Amsterdam 2022. Arnhem, The Netherlands: European Association of Urology Guidelines Office; 2022.
   Google Scholar
• Babjuk M, Burger M, Compérat E, et al. EAU guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS) 2022. European association of urology guidelines. 2022 Edition. Vol. presented at the EAU Annual Congress Amsterdam 2022. Arnhem, The Netherlands: European Association of Urology Guidelines Office; 2022.
   Google Scholar
• Suomen Syöpärekisteri/The Finnish Cancer Registry. https://cancerregistry.fi/statistics/cancer-statistics/. 2020.
   Google Scholar
• Bruins HM, Veskimae E, Hernandez V, et al. The importance of hospital and surgeon volume as major determinants of morbidity and mortality after radical cystectomy for bladder cancer: a systematic review and recommendations by the european association of urology muscle-invasive and metastatic bladder cancer guideline panel. Eur Urol Oncol. 2020;3(2):131–144. doi: 10.1016/j.euo.2019.11.005.
   PubMed Web of Science ®Google Scholar
• Finlex online database on legislative and other judicial information of Finland. https://www.finlex.fi/fi/laki/smur/2017/20170582. 2017.
   Google Scholar
• Hautmann RE, de Petriconi RC, Pfeiffer C, et al. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol. 2012;61(5):1039–1047. doi: 10.1016/j.eururo.2012.02.028.
   PubMed Web of Science ®Google Scholar
• Brierley J.D. ea. TNM classification of malignant tumors. 8th ed. Geneva: UICC International Union Against Cancer; Wiley 2017.
   Google Scholar
• Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349(9):859–866. doi: 10.1056/NEJMoa022148.
   PubMed Web of Science ®Google Scholar
• Yin M, Joshi M, Meijer RP, et al. Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis. Oncologist. 2016;21(6):708–715. doi: 10.1634/theoncologist.2015-0440.
   PubMed Web of Science ®Google Scholar
• Bjornsson O, Gudmundsson EO, Marteinsson VT, et al. Radical cystectomy in the treatment of bladder cancer in Iceland: a population-based study. Scand J Urol. 2016;50(1):65–70. doi: 10.3109/21681805.2015.1085088.
   PubMed Web of Science ®Google Scholar
• Coughlin GD, Youl PH, Philpot S, et al. Outcomes following radical cystectomy: a population-based study from Queensland, Australia. ANZ J Surg. 2019;89(6):752–757. doi: 10.1111/ans.15259.
   PubMed Web of Science ®Google Scholar
• Fedeli U, De Paoli A, Corti MC, et al. Perioperative mortality and long-term survival after radical cystectomy: a population-based study in a Southern European country on 4,389 patients. Urol Int. 2020;104(7–8):559–566. doi: 10.1159/000506240.
   PubMed Web of Science ®Google Scholar
• Goossens-Laan CA, Visser O, Hulshof MC, et al. Survival after treatment for carcinoma invading bladder muscle: a dutch population-based study on the impact of hospital volume. BJU Int. 2012;110(2):226–232. doi: 10.1111/j.1464-410X.2011.10694.x.
   PubMed Web of Science ®Google Scholar
• Haggstrom C, Garmo H, de Luna X, et al. Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer: a swedish nationwide population-based cohort study. Cancer Med. 2019;8(5):2196–2204. doi: 10.1002/cam4.2126.
   PubMed Web of Science ®Google Scholar
• Lund L, Jacobsen J, Clark P, et al. Impact of comorbidity on survival of invasive bladder cancer patients, 1996-2007: a Danish population-based cohort study. Urology. 2010;75(2):393–398. doi: 10.1016/j.urology.2009.07.1320.
   PubMed Web of Science ®Google Scholar
• Patel MI, Bang A, Gillatt D, et al. Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: a population-based study. BJU Int. 2015;116 Suppl 3(Suppl 3):18–25. doi: 10.1111/bju.13152
   PubMedGoogle Scholar
• Madersbacher S, Bauer W, Willinger M, et al. Radical cystectomy for bladder cancer in the 70+ population: a nation-wide registry analysis of 845 patients. Urol Int. 2010;85(3):287–290. doi: 10.1159/000316100.
   PubMed Web of Science ®Google Scholar
• Bostrom PJ, Mirtti T, Kossi J, et al. Twenty-year experience of radical cystectomy for bladder cancer in a medium-volume centre. Scand J Urol Nephrol. 2009;43(5):357–364. doi: 10.3109/00365590902939387.
   PubMed Web of Science ®Google Scholar
• Madersbacher S, Hochreiter W, Burkhard F, et al. Radical cystectomy for bladder cancer today–a homogeneous series without neoadjuvant therapy. J Clin Oncol. 2003;21(4):690–696. doi: 10.1200/JCO.2003.05.101.
   PubMed Web of Science ®Google Scholar
• Shariat SF, Karakiewicz PI, Palapattu GS, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium. J Urol. 2006;176(6 Pt 1):2414–2422; discussion 2422. doi: 10.1016/j.juro.2006.08.004.
   PubMed Web of Science ®Google Scholar
• Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19(3):666–675. doi: 10.1200/JCO.2001.19.3.666.
   PubMed Web of Science ®Google Scholar
• Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240(2):205–213. doi: 10.1097/01.sla.0000133083.54934.ae.
   PubMed Web of Science ®Google Scholar
• Leinonen MK, Miettinen J, Heikkinen S, et al. Quality measures of the population-based Finnish cancer registry indicate sound data quality for solid malignant tumours. Eur J Cancer. 2017;77:31–39. doi: 10.1016/j.ejca.2017.02.017.
   PubMed Web of Science ®Google Scholar
• Salama A, Abdelmaksoud AM, Shawki A, et al. Outcome of muscle-invasive urothelial bladder cancer after radical cystectomy. Clin Genitourin Cancer. 2016;14(1):e43-7–e47. doi: 10.1016/j.clgc.2015.07.007.
   PubMed Web of Science ®Google Scholar
• Lundberg FE, Andersson TM, Lambe M, et al. Trends in cancer survival in the Nordic countries 1990–2016: the NORDCAN survival studies. Acta Oncol. 2020;59(11):1266–1274. doi: 10.1080/0284186X.2020.1822544.
   PubMed Web of Science ®Google Scholar
• Palumbo C, Mistretta FA, Knipper S, et al. How cancer-specific mortality changes over time after radical cystectomy: conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder. Urol Oncol. 2019;37(12):893–899. doi: 10.1016/j.urolonc.2019.05.020.
   PubMed Web of Science ®Google Scholar
• Bruins HM, Huang GJ, Cai J, et al. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. J Urol. 2009;182(5):2182–2187. doi: 10.1016/j.juro.2009.07.017.
   PubMed Web of Science ®Google Scholar
• John JB, Varughese MA, Cooper N, et al. Treatment allocation and survival in patients diagnosed with nonmetastatic muscle-invasive bladder cancer: an analysis of a national patient cohort in England. Eur Urol Focus. 2021;7(2):359–365. doi: 10.1016/j.euf.2020.01.013.
   PubMedGoogle Scholar
• Aljabery F, Liedberg F, Haggstrom C, et al. Management and outcome of muscle-invasive bladder cancer with clinical lymph node metastases. A nationwide population-based study in the bladder cancer data base Sweden (BladderBaSe). Scand J Urol. 2019;53(5):332–338. doi: 10.1080/21681805.2019.1681504.
   PubMed Web of Science ®Google Scholar